MINERALYS THERAPEUTICS, INC. Accrued Employee Benefits
MINERALYS THERAPEUTICS, INC. (MLYS) had Accrued Employee Benefits of $1.22 million as of 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Notes › Accrued Liabilities
us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent · last filed 2023-11-07
- 2023-09-30: Accrued Employee Benefits $1.22M.
- 2023-06-30: Accrued Employee Benefits $764.00K.
- 2023-03-31: Accrued Employee Benefits $381.00K.
- 2022-12-31: Accrued Employee Benefits $665.00K.
| Period end | Accrued Employee Benefits |
|---|---|
| 2023-09-30 | $1.22M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $764.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $381.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $665.00K 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |